61 related articles for article (PubMed ID: 19901960)
1. Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q.
Fischer M; Bauer T; Oberthür A; Hero B; Theissen J; Ehrich M; Spitz R; Eils R; Westermann F; Brors B; König R; Berthold F
Oncogene; 2010 Feb; 29(6):865-75. PubMed ID: 19901960
[TBL] [Abstract][Full Text] [Related]
2. No evidence for involvement of SDHD in neuroblastoma pathogenesis.
De Preter K; Vandesompele J; Hoebeeck J; Vandenbroecke C; Smet J; Nuyts A; Laureys G; Combaret V; Van Roy N; Roels F; Van Coster R; Praet M; De Paepe A; Speleman F
BMC Cancer; 2004 Aug; 4():55. PubMed ID: 15331017
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and predictive biomarkers in paediatric solid tumours.
Glembocki AI; Somers GR
Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of neuroblastoma regression.
Brodeur GM; Bagatell R
Nat Rev Clin Oncol; 2014 Dec; 11(12):704-13. PubMed ID: 25331179
[TBL] [Abstract][Full Text] [Related]
5. Distinct evolutionary mechanisms for genomic imbalances in high-risk and low-risk neuroblastomas.
Gisselsson D; Lundberg G; Ora I; Höglund M
J Carcinog; 2007 Sep; 6():15. PubMed ID: 17897457
[TBL] [Abstract][Full Text] [Related]
6. Review of Patient Gene Profiles Obtained through a Non-Negative Matrix Factorization-Based Framework to Determine the Role Inflammation Plays in Neuroblastoma Pathogenesis.
Boccarelli A; Del Buono N; Esposito F
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673990
[TBL] [Abstract][Full Text] [Related]
7. Neuroblastoma of the lumbosacral canal in an adult: a case report and literature review.
Jiang Q; Gao H; Gao G; Li Y; Cheng H; Shi G; Shang A
Front Neurol; 2023; 14():1195664. PubMed ID: 37602246
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Next-Generation Sequencing and Fluorescence In Situ Hybridization for Detection of Segmental Chromosomal Aberrations in Neuroblastoma.
Kim E; Lee B; Lee JW; Sung KW; Kim JS
Diagnostics (Basel); 2021 Sep; 11(9):. PubMed ID: 34574043
[TBL] [Abstract][Full Text] [Related]
9. Investigation of major genetic alterations in neuroblastoma.
Costa RA; Seuánez HN
Mol Biol Rep; 2018 Jun; 45(3):287-295. PubMed ID: 29455316
[TBL] [Abstract][Full Text] [Related]
10. 11q deletion in neuroblastoma: a review of biological and clinical implications.
Mlakar V; Jurkovic Mlakar S; Lopez G; Maris JM; Ansari M; Gumy-Pause F
Mol Cancer; 2017 Jun; 16(1):114. PubMed ID: 28662712
[TBL] [Abstract][Full Text] [Related]
11.
Yue ZX; Huang C; Gao C; Xing TY; Liu SG; Li XJ; Zhao Q; Wang XS; Zhao W; Jin M; Ma XL
Cancer Cell Int; 2017; 17():43. PubMed ID: 28367105
[No Abstract] [Full Text] [Related]
12. Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma.
Ikram F; Ackermann S; Kahlert Y; Volland R; Roels F; Engesser A; Hertwig F; Kocak H; Hero B; Dreidax D; Henrich KO; Berthold F; Nürnberg P; Westermann F; Fischer M
Mol Oncol; 2016 Feb; 10(2):344-59. PubMed ID: 26598443
[TBL] [Abstract][Full Text] [Related]
13. FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma.
Ackermann S; Kocak H; Hero B; Ehemann V; Kahlert Y; Oberthuer A; Roels F; Theißen J; Odenthal M; Berthold F; Fischer M
BMC Cancer; 2014 Nov; 14():840. PubMed ID: 25406647
[TBL] [Abstract][Full Text] [Related]
14. Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.
Defferrari R; Mazzocco K; Ambros IM; Ambros PF; Bedwell C; Beiske K; Bénard J; Berbegall AP; Bown N; Combaret V; Couturier J; Erminio G; Gambini C; Garaventa A; Gross N; Haupt R; Kohler J; Jeison M; Lunec J; Marques B; Martinsson T; Noguera R; Parodi S; Schleiermacher G; Tweddle DA; Valent A; Van Roy N; Vicha A; Villamon E; Tonini GP
Br J Cancer; 2015 Jan; 112(2):290-5. PubMed ID: 25356804
[TBL] [Abstract][Full Text] [Related]
15. Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation.
Cetinkaya C; Martinsson T; Sandgren J; Träger C; Kogner P; Dumanski J; Díaz de Ståhl T; Hedborg F
BMC Cancer; 2013 May; 13():231. PubMed ID: 23656755
[TBL] [Abstract][Full Text] [Related]
16. Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma.
Kocak H; Ackermann S; Hero B; Kahlert Y; Oberthuer A; Juraeva D; Roels F; Theissen J; Westermann F; Deubzer H; Ehemann V; Brors B; Odenthal M; Berthold F; Fischer M
Cell Death Dis; 2013 Apr; 4(4):e586. PubMed ID: 23579273
[TBL] [Abstract][Full Text] [Related]
17. Genetic instability and intratumoral heterogeneity in neuroblastoma with MYCN amplification plus 11q deletion.
Villamón E; Berbegall AP; Piqueras M; Tadeo I; Castel V; Djos A; Martinsson T; Navarro S; Noguera R
PLoS One; 2013; 8(1):e53740. PubMed ID: 23341988
[TBL] [Abstract][Full Text] [Related]
18. The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.
Domingo-Fernandez R; Watters K; Piskareva O; Stallings RL; Bray I
Pediatr Surg Int; 2013 Feb; 29(2):101-19. PubMed ID: 23274701
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis of neuroblastoma and pheochromocytoma genomics data.
Szabó PM; Pintér M; Szabó DR; Zsippai A; Patócs A; Falus A; Rácz K; Igaz P
BMC Med Genomics; 2012 Oct; 5():48. PubMed ID: 23106811
[TBL] [Abstract][Full Text] [Related]
20. Frequent loss of the BLID gene in early-onset breast cancer.
Cavalli LR; Noone AM; Makambi KH; Rone JD; Kasid UN; Haddad BR
Cytogenet Genome Res; 2011; 135(1):19-24. PubMed ID: 21846966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
